Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Jan-24 6:18 PM View:  | An2 Therapeutics, Inc. (ANTX) | 16-Jan-24 | Private Sale | 84,093 | $19.65 | $1,652,430.00 | (3%) 2.47M to 2.39M | |
| 18-Jan-24 6:18 PM View: | An2 Therapeutics, Inc. (ANTX) | 16-Jan-24 | Sale | 15,907 | $19.65 | $312,573.00 | (< 1%) 2.39M to 2.37M | |
| 16-Nov-23 6:59 PM View: | An2 Therapeutics, Inc. (ANTX) | 14-Nov-23 | Market Sale (Planned) | 1,522 | $16.15 | $24,574.20 | (< 1%) 2.48M to 2.47M | 7% |
| 16-Nov-23 6:59 PM View: | An2 Therapeutics, Inc. (ANTX) | 14-Nov-23 | Market Sale (Planned) | 288 | $16.15 | $4,650.05 | (< 1%) 2.47M to 2.47M | 7% |
| 03-Oct-23 10:00 PM View: | An2 Therapeutics, Inc. (ANTX) | 02-Oct-23 | Sale (Planned) | 4,770 | $16.07 | $76,653.90 | (< 1%) 2.48M to 2.48M | |
| 03-Oct-23 10:00 PM View: | An2 Therapeutics, Inc. (ANTX) | 02-Oct-23 | Sale (Planned) | 902 | $16.07 | $14,495.10 | (< 1%) 2.48M to 2.48M | |
| 03-Oct-23 10:00 PM View: | An2 Therapeutics, Inc. (ANTX) | 29-Sep-23 | Private Sale (Planned) | 83,337 | $16.28 | $1,356,730.00 | (3%) 2.58M to 2.5M | |
| 03-Oct-23 10:00 PM View: | An2 Therapeutics, Inc. (ANTX) | 29-Sep-23 | Sale (Planned) | 15,764 | $16.28 | $256,638.00 | (< 1%) 2.5M to 2.48M | |
| 29-Sep-23 5:41 PM View: | An2 Therapeutics, Inc. (ANTX) | 28-Sep-23 | Market Sale (Planned) | 7,160 | $16.11 | $115,348.00 | (< 1%) 2.59M to 2.58M | 7% |
| 29-Sep-23 5:41 PM View: | An2 Therapeutics, Inc. (ANTX) | 28-Sep-23 | Market Sale (Planned) | 1,356 | $16.11 | $21,845.20 | (< 1%) 2.58M to 2.58M | 7% |
| 29-Sep-23 5:41 PM View: | An2 Therapeutics, Inc. (ANTX) | 27-Sep-23 | Market Sale (Planned) | 707 | $16.07 | $11,361.50 | (< 1%) 2.59M to 2.59M | 7% |
| 29-Sep-23 5:41 PM View: | An2 Therapeutics, Inc. (ANTX) | 27-Sep-23 | Market Sale (Planned) | 134 | $16.07 | $2,153.38 | (< 1%) 2.59M to 2.59M | 7% |
| 15-Sep-23 5:17 PM View: | An2 Therapeutics, Inc. (ANTX) | 13-Sep-23 | Market Sale (Planned) | 336 | $16.00 | $5,376.00 | (< 1%) 2.59M to 2.59M | 6% |
| 15-Sep-23 5:17 PM View: | An2 Therapeutics, Inc. (ANTX) | 13-Sep-23 | Market Sale (Planned) | 64 | $16.00 | $1,024.00 | (< 1%) 2.59M to 2.59M | 6% |
| 08-Sep-23 4:59 PM View: | An2 Therapeutics, Inc. (ANTX) | 07-Sep-23 | Market Sale (Planned) | 2,841 | $16.05 | $45,598.00 | (< 1%) 2.59M to 2.59M | 6% |
| 08-Sep-23 4:59 PM View: | An2 Therapeutics, Inc. (ANTX) | 07-Sep-23 | Market Sale (Planned) | 537 | $16.05 | $8,618.85 | (< 1%) 2.59M to 2.59M | 6% |
| 08-Sep-23 4:59 PM View: | An2 Therapeutics, Inc. (ANTX) | 06-Sep-23 | Market Sale (Planned) | 3,164 | $16.02 | $50,687.30 | (< 1%) 2.6M to 2.59M | 6% |
| 08-Sep-23 4:59 PM View: | An2 Therapeutics, Inc. (ANTX) | 06-Sep-23 | Market Sale (Planned) | 598 | $16.02 | $9,579.96 | (< 1%) 2.59M to 2.59M | 6% |
| 25-Aug-23 4:31 PM View: | An2 Therapeutics, Inc. (ANTX) | 23-Aug-23 | Market Sale | 336 | $16.00 | $5,376.00 | (< 1%) 2.6M to 2.6M | 6% |
| 25-Aug-23 4:31 PM View: | An2 Therapeutics, Inc. (ANTX) | 23-Aug-23 | Market Sale | 64 | $16.00 | $1,024.00 | (< 1%) 2.6M to 2.6M | 6% |
| 24-Jun-22 5:06 PM View: | An2 Therapeutics, Inc. (ANTX) | 06-Jun-22 | Acquisition (other) Duplicate | 26,511 | $15.00 | $397,665.00 | 1% 2.6M to 2.62M | < 1% |
| 24-Jun-22 5:06 PM View: | An2 Therapeutics, Inc. (ANTX) | 06-Jun-22 | Disposition (other) | 26,511 | $15.00 | $397,665.00 | (1%) 2.62M to 2.6M | (< 1%) |
| 31-Mar-22 8:15 PM View: | An2 Therapeutics, Inc. (ANTX) | 29-Mar-22 | Conversion Duplicate | 2,430,710 | -- | -- | 100% 0 to 2.43M | |
| 31-Mar-22 8:15 PM View: | An2 Therapeutics, Inc. (ANTX) | 29-Mar-22 | Market Purchase Duplicate | 166,666 | $15.00 | $2,499,990.00 | 7% 2.43M to 2.6M |